EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2

Na Li, Jiali Deng, Junli Zhang, Fei Yu, Fanghang Ye, Liyuan Hao, Shenghao Li, Xiaoyu Hu

Inflammation · 2024-10 · 47 (5) · 1634-1647

DOI: 10.1007/s10753-024-01998-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammation, online erschienen am 02.03.2024. Verfasst von Na Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Uncoupling Protein 2, Sepsis, Glycolysis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Sichuan Provincial Administration of Traditional Chinese Medicine Major Science and Technology projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a severe and life-threatening disease caused by infection, characterized by a dysregulated immune response. Unfortunately, effective treatment strategies for sepsis are still lacking. The intricate interplay between metabolism and the immune system limits the treatment options for sepsis. During sepsis, there is a profound shift in cellular energy metabolism, which triggers a metabolic reprogramming of immune cells. This metabolic alteration impairs immune responses, giving rise to excessive inflammation and immune suppression. Recent research has demonstrated that UCP2 not only serves as a critical target in sepsis but also functions as a key metabolic switch involved in immune cell-mediated inflammatory responses. However, the regulatory mechanisms underlying this modulation are complex. This article focuses on UCP2 as a target and discusses metabolic reprogramming during sepsis and the complex regulatory mechanisms between different stages of inflammation. Our research indicates that overexpression of UCP2 reduces the Warburg effect, restores mitochondrial function, and improves the prognosis of sepsis. This discovery aims to provide a promising approach to address the significant challenges associated with metabolic dysfunction and immune paralysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uncoupling Protein 2SepsisGlycolysisHumansAnimalsInflammationEnergy MetabolismMitochondria

Stichwörter der Autor:innen

Excessive inflammationGlycolysisImmune suppressionSepsisUCP2 overexpression

Substanzen

Uncoupling Protein 2UCP2 protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, China.
  • Department of Infectious Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. TCMxiaoyuhu@aliyun.com.

Förderung

  • the National Natural Science Foundation of China
  • Sichuan Provincial Administration of Traditional Chinese Medicine Major Science and Technology projects

Zitieren

APA

Li, N., Deng, J., Zhang, J., Yu, F., Ye, F., Hao, L., Li, S., & Hu, X. (2024). A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2. Inflammation, 47(5), 1634-1647. https://doi.org/10.1007/s10753-024-01998-4

Vancouver

Li N, Deng J, Zhang J, Yu F, Ye F, Hao L, et al. A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2. Inflammation. 2024;47(5):1634-1647. doi:10.1007/s10753-024-01998-4

BibTeX
@article{Li2024,
  author = {Li, Na and Deng, Jiali and Zhang, Junli and Yu, Fei and Ye, Fanghang and Hao, Liyuan and Li, Shenghao and Hu, Xiaoyu},
  title = {A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2},
  journal = {Inflammation},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {1634--1647},
  doi = {10.1007/s10753-024-01998-4}
}
Kostenlos starten →